FELODIPINEEXTENDED-RELEASE TABLETS (Ranbaxy Pharmaceuticals Inc)
Welcome to the PulseAid listing for the FELODIPINEEXTENDED-RELEASE TABLETS drug offered from Ranbaxy Pharmaceuticals Inc. This Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Ranbaxy Pharmaceuticals Inc |
NON-PROPRIETARY NAME: | felodipine |
SUBSTANCE NAME: | FELODIPINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2008-09-10 |
END MARKETING DATE: | 0000-00-00 |
FELODIPINEEXTENDED-RELEASE TABLETS HUMAN PRESCRIPTION DRUG Details:
Item Description | FELODIPINEEXTENDED-RELEASE TABLETS from Ranbaxy Pharmaceuticals Inc |
LABELER NAME: | Ranbaxy Pharmaceuticals Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2.5(mg/1) |
START MARKETING DATE: | 2008-09-10 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63304-435_b951455c-c235-4e23-9e21-08672d108726 |
PRODUCT NDC: | 63304-435 |
APPLICATION NUMBER: | NDA019834 |
Other FELODIPINE Pharmaceutical Manufacturers / Labelers: